Selected research
Market Structure
Global Medical Inhalation Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Inhalation Anesthetics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Inhalation Anesthetics include Sandoz International GmbH (Novartis), Novartis AG, Lunan Pharmaceutical Group Co. Ltd., Jiangsu Hengrui Medicine Co. Ltd., Fresenius SE & Co., Baxter International Inc., AbbVie Inc., Troikaa Pharmaceuticals, Ltd and Piramal Enterprises Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medical Inhalation Anesthetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Inhalation Anesthetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Inhalation Anesthetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Inhalation Anesthetics market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Inhalation Anesthetics Segment by Company
Sandoz International GmbH (Novartis)
Novartis AG
Lunan Pharmaceutical Group Co. Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius SE & Co.
Baxter International Inc.
AbbVie Inc.
Troikaa Pharmaceuticals, Ltd
Piramal Enterprises Ltd.
Maruishi Pharmaceutical
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Abbott Laboratories
Medical Inhalation Anesthetics Segment by Type
Isoflurane
Nitrous Oxide
Sevoflurane
Halothane
Desflurane
Others
Medical Inhalation Anesthetics Segment by Application
Hospitals
Ambulatory Surgical Centres
Others
Medical Inhalation Anesthetics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Inhalation Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Inhalation Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Inhalation Anesthetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Inhalation Anesthetics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Inhalation Anesthetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Inhalation Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medical Inhalation Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Isoflurane
- Nitrous Oxide
- Sevoflurane
- Halothane
- Desflurane
- Others
Applications
- Hospitals
- Ambulatory Surgical Centres
- Others
Companies covered
- Sandoz International GmbH (Novartis)
- Novartis AG
- Lunan Pharmaceutical Group Co. Ltd.
- Jiangsu Hengrui Medicine Co. Ltd.
- Fresenius SE & Co.
- Baxter International Inc.
- AbbVie Inc.
- Troikaa Pharmaceuticals, Ltd
- Piramal Enterprises Ltd.
- Maruishi Pharmaceutical
- Hikma Pharmaceuticals PLC
- Halocarbon Products Corporation
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Inhalation Anesthetics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Inhalation Anesthetics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medical Inhalation Anesthetics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medical Inhalation Anesthetics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medical Inhalation Anesthetics Market Dynamics
- 2.1 Medical Inhalation Anesthetics Industry Trends
- 2.2 Medical Inhalation Anesthetics Industry Drivers
- 2.3 Medical Inhalation Anesthetics Industry Opportunities and Challenges
- 2.4 Medical Inhalation Anesthetics Industry Restraints
3 Medical Inhalation Anesthetics Market by Manufacturers
- 3.1 Global Medical Inhalation Anesthetics Revenue by Manufacturers (2021-2026)
- 3.2 Global Medical Inhalation Anesthetics Sales by Manufacturers (2021-2026)
- 3.3 Global Medical Inhalation Anesthetics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medical Inhalation Anesthetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Inhalation Anesthetics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Inhalation Anesthetics Manufacturers, Product Type & Application
- 3.7 Global Medical Inhalation Anesthetics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Inhalation Anesthetics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Inhalation Anesthetics Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Inhalation Anesthetics Tier 1, Tier 2, and Tier 3
4 Medical Inhalation Anesthetics Market by Type
- 4.1 Medical Inhalation Anesthetics Type Introduction
- 4.1.1 Isoflurane
- 4.1.2 Nitrous Oxide
- 4.1.3 Sevoflurane
- 4.1.4 Halothane
- 4.1.5 Desflurane
- 4.1.6 Others
- 4.2 Global Medical Inhalation Anesthetics Sales by Type
- 4.2.1 Global Medical Inhalation Anesthetics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Inhalation Anesthetics Sales by Type (2021-2032)
- 4.2.3 Global Medical Inhalation Anesthetics Sales Market Share by Type (2021-2032)
- 4.3 Global Medical Inhalation Anesthetics Revenue by Type
- 4.3.1 Global Medical Inhalation Anesthetics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Inhalation Anesthetics Revenue by Type (2021-2032)
- 4.3.3 Global Medical Inhalation Anesthetics Revenue Market Share by Type (2021-2032)
5 Medical Inhalation Anesthetics Market by Application
- 5.1 Medical Inhalation Anesthetics Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Ambulatory Surgical Centres
- 5.1.3 Others
- 5.2 Global Medical Inhalation Anesthetics Sales by Application
- 5.2.1 Global Medical Inhalation Anesthetics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Inhalation Anesthetics Sales by Application (2021-2032)
- 5.2.3 Global Medical Inhalation Anesthetics Sales Market Share by Application (2021-2032)
- 5.3 Global Medical Inhalation Anesthetics Revenue by Application
- 5.3.1 Global Medical Inhalation Anesthetics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Inhalation Anesthetics Revenue by Application (2021-2032)
- 5.3.3 Global Medical Inhalation Anesthetics Revenue Market Share by Application (2021-2032)
6 Global Medical Inhalation Anesthetics Sales by Region
- 6.1 Global Medical Inhalation Anesthetics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Inhalation Anesthetics Sales by Region (2021-2032)
- 6.2.1 Global Medical Inhalation Anesthetics Sales by Region (2021-2026)
- 6.2.2 Global Medical Inhalation Anesthetics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Inhalation Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medical Inhalation Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medical Inhalation Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medical Inhalation Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medical Inhalation Anesthetics Revenue by Region
- 7.1 Global Medical Inhalation Anesthetics Revenue by Region
- 7.1.1 Global Medical Inhalation Anesthetics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medical Inhalation Anesthetics Revenue by Region (2021-2026)
- 7.1.3 Global Medical Inhalation Anesthetics Revenue by Region (2027-2032)
- 7.1.4 Global Medical Inhalation Anesthetics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medical Inhalation Anesthetics Revenue (2021-2032)
- 7.2.2 North America Medical Inhalation Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medical Inhalation Anesthetics Revenue (2021-2032)
- 7.3.2 Europe Medical Inhalation Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medical Inhalation Anesthetics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medical Inhalation Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medical Inhalation Anesthetics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medical Inhalation Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sandoz International GmbH (Novartis)
- 8.1.1 Sandoz International GmbH (Novartis) Company Information
- 8.1.2 Sandoz International GmbH (Novartis) Business Overview
- 8.1.3 Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Product Portfolio
- 8.1.5 Sandoz International GmbH (Novartis) Recent Developments
- 8.2 Novartis AG
- 8.2.1 Novartis AG Company Information
- 8.2.2 Novartis AG Business Overview
- 8.2.3 Novartis AG Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis AG Medical Inhalation Anesthetics Product Portfolio
- 8.2.5 Novartis AG Recent Developments
- 8.3 Lunan Pharmaceutical Group Co. Ltd.
- 8.3.1 Lunan Pharmaceutical Group Co. Ltd. Company Information
- 8.3.2 Lunan Pharmaceutical Group Co. Ltd. Business Overview
- 8.3.3 Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Product Portfolio
- 8.3.5 Lunan Pharmaceutical Group Co. Ltd. Recent Developments
- 8.4 Jiangsu Hengrui Medicine Co. Ltd.
- 8.4.1 Jiangsu Hengrui Medicine Co. Ltd. Company Information
- 8.4.2 Jiangsu Hengrui Medicine Co. Ltd. Business Overview
- 8.4.3 Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Product Portfolio
- 8.4.5 Jiangsu Hengrui Medicine Co. Ltd. Recent Developments
- 8.5 Fresenius SE & Co.
- 8.5.1 Fresenius SE & Co. Company Information
- 8.5.2 Fresenius SE & Co. Business Overview
- 8.5.3 Fresenius SE & Co. Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Fresenius SE & Co. Medical Inhalation Anesthetics Product Portfolio
- 8.5.5 Fresenius SE & Co. Recent Developments
- 8.6 Baxter International Inc.
- 8.6.1 Baxter International Inc. Company Information
- 8.6.2 Baxter International Inc. Business Overview
- 8.6.3 Baxter International Inc. Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Baxter International Inc. Medical Inhalation Anesthetics Product Portfolio
- 8.6.5 Baxter International Inc. Recent Developments
- 8.7 AbbVie Inc.
- 8.7.1 AbbVie Inc. Company Information
- 8.7.2 AbbVie Inc. Business Overview
- 8.7.3 AbbVie Inc. Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 AbbVie Inc. Medical Inhalation Anesthetics Product Portfolio
- 8.7.5 AbbVie Inc. Recent Developments
- 8.8 Troikaa Pharmaceuticals, Ltd
- 8.8.1 Troikaa Pharmaceuticals, Ltd Company Information
- 8.8.2 Troikaa Pharmaceuticals, Ltd Business Overview
- 8.8.3 Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Product Portfolio
- 8.8.5 Troikaa Pharmaceuticals, Ltd Recent Developments
- 8.9 Piramal Enterprises Ltd.
- 8.9.1 Piramal Enterprises Ltd. Company Information
- 8.9.2 Piramal Enterprises Ltd. Business Overview
- 8.9.3 Piramal Enterprises Ltd. Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Piramal Enterprises Ltd. Medical Inhalation Anesthetics Product Portfolio
- 8.9.5 Piramal Enterprises Ltd. Recent Developments
- 8.10 Maruishi Pharmaceutical
- 8.10.1 Maruishi Pharmaceutical Company Information
- 8.10.2 Maruishi Pharmaceutical Business Overview
- 8.10.3 Maruishi Pharmaceutical Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Maruishi Pharmaceutical Medical Inhalation Anesthetics Product Portfolio
- 8.10.5 Maruishi Pharmaceutical Recent Developments
- 8.11 Hikma Pharmaceuticals PLC
- 8.11.1 Hikma Pharmaceuticals PLC Company Information
- 8.11.2 Hikma Pharmaceuticals PLC Business Overview
- 8.11.3 Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Product Portfolio
- 8.11.5 Hikma Pharmaceuticals PLC Recent Developments
- 8.12 Halocarbon Products Corporation
- 8.12.1 Halocarbon Products Corporation Company Information
- 8.12.2 Halocarbon Products Corporation Business Overview
- 8.12.3 Halocarbon Products Corporation Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Halocarbon Products Corporation Medical Inhalation Anesthetics Product Portfolio
- 8.12.5 Halocarbon Products Corporation Recent Developments
- 8.13 Abbott Laboratories
- 8.13.1 Abbott Laboratories Company Information
- 8.13.2 Abbott Laboratories Business Overview
- 8.13.3 Abbott Laboratories Medical Inhalation Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Abbott Laboratories Medical Inhalation Anesthetics Product Portfolio
- 8.13.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Inhalation Anesthetics Value Chain Analysis
- 9.1.1 Medical Inhalation Anesthetics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Inhalation Anesthetics Production Mode & Process
- 9.2 Medical Inhalation Anesthetics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Inhalation Anesthetics Distributors
- 9.2.3 Medical Inhalation Anesthetics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst